Participation in International Multicentre Clinical Trials began at The Queen Elizabeth Hospital (TQEH) Renal Unit in 1992. From our first international immunosuppression clinical trial, the pivotal registration study for Mycophenolate Mofetil, with one staff member working one day a week, the unit is currently participating in 25 studies in 2008 requiring 4.5 full time equivalent staff members.
With the success of this initial study in 1992, both clinically and in accuracy of data collection, the reputation of the The Queen Elizabeth Renal Unit became well known. With the outcome of this success, the Renal Unit was approached to participate in more ground breaking international multicentre clinical trials branching out into pre dialysis/ chronic kidney disease, dialysis and transplantation studies.
This poster will give an overview of the evolution of clinical trials and the role they have played in the advancement in care of the renal patient.